Latest stories on XBIO
Xenetic Biosciences, Inc. (XBIO) M&A Call Prepared Remarks Transcript
Seeking Alpha50 · neutralm&a
Xenetic Biosciences Announces All-Stock Merger with Santersus, Leaving Existing Shareholders with 15% Stake
InvestorsHub48 · neutralm&a
Micro Cap Xenetic Biosciences Expands Therapeutic Platform With Santersus Acquisition
Yahoo Top63 · neutralm&a
Xenetic Biosciences to Acquire Santersus AG in Merger
TipRanks62 · neutralm&a
Xenetic Biosciences in Reverse Merger Pact With Santersus
MarketWatch56 · neutralm&a
Xenetic, Santerus enter definitive share exchange agreement
The Fly62 · neutralm&a
Xenetic Biosciences, Inc. (XBIO) files 8-K
SEC 8-K50 · neutralgeneral
Xenetic Reports Q2 Eps 41c Vs 45c Last Year
The Fly48 · neutralearnings
Xenetic Biosciences reports Q2 results
Seeking Alpha55 · neutralearnings
Xenetic Biosciences, Inc. (XBIO) files 8-K
SEC 8-K50 · neutralgeneral
Xenetic Biosciences, Inc. Announces That Its Collaboration Partner Received Approval From the Israeli Ministry of Health to Conduct Exploratory, Investigator Initiated Study of DNase I In Combination With Anti-CD19 CAR T Cells in Large B-Cell Lymphoma | XBIO Stock News
StockTitan63 · neutralproduct/pr